Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$250,000
$50.55 P/Share
|
|
Nov 18
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Nov 12
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
6,342
-2.66%
|
$367,836
$58.48 P/Share
|
|
Nov 12
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+4.22%
|
$37,100
$7.96 P/Share
|
|
Nov 01
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$255,000
$51.63 P/Share
|
|
Nov 01
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Oct 30
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-3.02%
|
$372,300
$51.92 P/Share
|
|
Oct 30
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+4.16%
|
$37,100
$7.96 P/Share
|
|
Oct 28
2024
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
4,452
-15.35%
|
$231,504
$52.25 P/Share
|
|
Oct 28
2024
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,452
+13.3%
|
$31,164
$7.37 P/Share
|
|
Oct 15
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.97%
|
$394,200
$54.19 P/Share
|
|
Oct 15
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+4.09%
|
$37,100
$7.96 P/Share
|
|
Oct 09
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$275,000
$55.61 P/Share
|
|
Oct 09
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Oct 01
2024
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
118
+0.48%
|
$6,136
$52.6 P/Share
|
|
Oct 01
2024
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+0.93%
|
$12,324
$52.6 P/Share
|
|
Oct 01
2024
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
403
+1.04%
|
$20,956
$52.6 P/Share
|
|
Oct 01
2024
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+1.48%
|
$12,324
$52.6 P/Share
|
|
Oct 01
2024
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
118
+0.51%
|
$6,136
$52.6 P/Share
|
|
Oct 01
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.96%
|
$379,600
$52.1 P/Share
|
|
Oct 01
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+4.09%
|
$37,100
$7.96 P/Share
|
|
Sep 30
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$260,000
$52.14 P/Share
|
|
Sep 30
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Sep 17
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.88%
|
$408,800
$56.76 P/Share
|
|
Sep 17
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.97%
|
$37,100
$7.96 P/Share
|
|
Sep 16
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$275,000
$55.99 P/Share
|
|
Sep 16
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Sep 09
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$270,000
$54.92 P/Share
|
|
Sep 09
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Sep 03
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,384
-2.9%
|
$420,888
$57.01 P/Share
|
|
Sep 03
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.97%
|
$37,100
$7.96 P/Share
|
|
Sep 03
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$285,000
$57.03 P/Share
|
|
Sep 03
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Aug 30
2024
|
Brett A Pletcher EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,140
+50.0%
|
-
|
|
Aug 26
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$285,000
$57.26 P/Share
|
|
Aug 26
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Aug 20
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.82%
|
$408,800
$56.24 P/Share
|
|
Aug 20
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.91%
|
$37,100
$7.96 P/Share
|
|
Aug 19
2024
|
Robert I Blum President & CEO |
SELL
Bona fide gift
|
Direct |
1,956
-0.49%
|
-
|
|
Aug 12
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$275,000
$55.2 P/Share
|
|
Aug 12
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Aug 12
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.8%
|
$632,500
$55.17 P/Share
|
|
Aug 12
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+2.72%
|
$69,000
$6.67 P/Share
|
|
Aug 07
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+4.01%
|
$37,100
$7.96 P/Share
|
|
Aug 06
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.86%
|
$386,900
$53.72 P/Share
|
|
Jul 30
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.8%
|
$678,500
$59.49 P/Share
|
|
Jul 30
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+2.72%
|
$69,000
$6.67 P/Share
|
|
Jul 29
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$295,000
$59.84 P/Share
|
|
Jul 29
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Jul 23
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.74%
|
$416,100
$57.02 P/Share
|